As of 2025-06-21, the Intrinsic Value of Anthera Pharmaceuticals Inc (ANTH) is -4.47 USD. This ANTH valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Anthera Pharmaceuticals Inc is -4,467,440.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Anthera Pharmaceuticals Inc (ANTH) is overvalued by 4,467,440.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.47 - -4.47 | -4.47 | -4,467,440.00% |
| DDM - Stable | (8.16) - (52.20) | (30.18) | -30182032.8% |
| DDM - Multi | (8.45) - (44.09) | (14.40) | -14399488.8% |
| Market Cap (mil) | 0.00 |
| Beta | -28.08 |
| Outstanding shares (mil) | 26.18 |
| Enterprise Value (mil) | -8.08 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.60% |
| Cost of Debt | 5.00% |
| WACC | 6.14% |